Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective

© 2017, Springer Science+Business Media New York. Human papillomavirus (HPV) associated head and neck squamous cell carcinomas (HNSCCs), have become a serious global health problem. Despite decreases in HPV-negative HNSCCs, the prevalence of HPV-positive HNSCCs has significantly increased. HPV-posit...

Full description

Bibliographic Details
Main Authors: Aldalwg, M., Brestovac, Brian
Format: Journal Article
Published: 2017
Online Access:http://hdl.handle.net/20.500.11937/56804
_version_ 1848759942487474176
author Aldalwg, M.
Brestovac, Brian
author_facet Aldalwg, M.
Brestovac, Brian
author_sort Aldalwg, M.
building Curtin Institutional Repository
collection Online Access
description © 2017, Springer Science+Business Media New York. Human papillomavirus (HPV) associated head and neck squamous cell carcinomas (HNSCCs), have become a serious global health problem. Despite decreases in HPV-negative HNSCCs, the prevalence of HPV-positive HNSCCs has significantly increased. HPV-positive cancers are associated with superior survival outcomes when compared to HPV-negative cancers, which appears likely to be associated with differences in the molecular pathogenesis of the two diseases. While therapies are still problematic, the current HPV vaccine programs hold a promise for the primary prevention of HPV-related HNSCCs and since Australia was the first to introduce a nationwide HPV vaccine program, it is in a unique position to observe the effects of the vaccine on HNSCCs. This review discusses the epidemiological trends associated with HPV in HNSCC, with reference to the differences between HPV-positive and HPV-negative HNSCCs and the prevention potential of HPV vaccines.
first_indexed 2025-11-14T10:07:54Z
format Journal Article
id curtin-20.500.11937-56804
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:07:54Z
publishDate 2017
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-568042018-03-29T09:08:24Z Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective Aldalwg, M. Brestovac, Brian © 2017, Springer Science+Business Media New York. Human papillomavirus (HPV) associated head and neck squamous cell carcinomas (HNSCCs), have become a serious global health problem. Despite decreases in HPV-negative HNSCCs, the prevalence of HPV-positive HNSCCs has significantly increased. HPV-positive cancers are associated with superior survival outcomes when compared to HPV-negative cancers, which appears likely to be associated with differences in the molecular pathogenesis of the two diseases. While therapies are still problematic, the current HPV vaccine programs hold a promise for the primary prevention of HPV-related HNSCCs and since Australia was the first to introduce a nationwide HPV vaccine program, it is in a unique position to observe the effects of the vaccine on HNSCCs. This review discusses the epidemiological trends associated with HPV in HNSCC, with reference to the differences between HPV-positive and HPV-negative HNSCCs and the prevention potential of HPV vaccines. 2017 Journal Article http://hdl.handle.net/20.500.11937/56804 10.1007/s12105-017-0780-7 restricted
spellingShingle Aldalwg, M.
Brestovac, Brian
Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective
title Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective
title_full Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective
title_fullStr Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective
title_full_unstemmed Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective
title_short Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective
title_sort human papillomavirus associated cancers of the head and neck: an australian perspective
url http://hdl.handle.net/20.500.11937/56804